Mesenchymal stromal cells (MSCs) are multipotent cells found in connective tissues that can differentiate into bone, cartilage, and adipose tissue. Interestingly, they can regulate immune responses in a paracrine way and allogeneic MSCs do not elicit immune response. These properties have encouraged a number of clinical trials in a broad range of regenerative therapies. Although these trials were first focused on their differentiation properties, in the last years, the immunosuppressive features have gained most of the attention. In this review, we will summarize the up-to-date knowledge about the immunosuppressive mechanisms of MSCs in vivo and in vitro and the most promising approaches in clinical investigation.
Keyphrases
- mesenchymal stem cells
- bone marrow
- immune response
- umbilical cord
- cell therapy
- adipose tissue
- clinical trial
- induced apoptosis
- endothelial cells
- dendritic cells
- healthcare
- single cell
- cell cycle arrest
- gene expression
- toll like receptor
- stem cells
- insulin resistance
- high fat diet
- stem cell transplantation
- bone mineral density
- working memory
- induced pluripotent stem cells
- randomized controlled trial
- metabolic syndrome
- pluripotent stem cells
- skeletal muscle
- low dose
- signaling pathway
- type diabetes
- high dose
- phase ii
- soft tissue